Clinical trial
Comparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIB®…
NCT00362336 · Sanofi Pasteur, a Sanofi Company, Industry · Completed
Key facts
| NCT number | NCT00362336 |
|---|---|
| Title | Comparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPV |
| Official title | Immunogenicity Study of a DTaP-IPV-Hep B-PRP~T Combined Vaccine in Comparison to CombAct-HIB® Concomitantly Administered With Engerix B® Paediatric and OPV at 6, 10, and 14 Weeks of Age in South African Infants |
| Lead sponsor | Sanofi Pasteur, a Sanofi Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatitis B, Polio, Diphtheria, Pertussis, Haemophilus Influenzae Type b |
| Intervention type | Biological |
| Interventions | DTaP-IPV-HB-PRP~T, CombAct-HIB®, Engerix B® Pediatric |
| Enrollment | 622 |
| Start date | Aug 1, 2006 |
| Primary completion | May 1, 2008 |
| Completion | Aug 1, 2009 |
| First posted | Aug 10, 2006 |
| Last update posted | May 2, 2014 |
| Countries | South Africa |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: